img

Global Aciclovir Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Aciclovir Market Research Report 2024

Aciclovir (ACV), also known as acyclovir, is an antiviral medication. It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles. Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein-Barr virus infection.
According to Mr Accuracy reports’s new survey, global Aciclovir market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Aciclovir market research.
Key manufacturers engaged in the Aciclovir industry include Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, Novartis, Teva, Stada Nordic and Cimed Industria de Medicamentos, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Aciclovir were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Aciclovir market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Aciclovir market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Greater Pharma
LBS Labs
GlaxoSmithKline
Lex Ano
Salutas
Novartis
Teva
Stada Nordic
Cimed Industria de Medicamentos
Reman Drug
L.E.T.I.
Nichi-Iko Pharmaceutical
Choseido Pharmaceutical
Shiono Kemikaru
Towa Yakuhin
Wockhardt
Takata Pharmaceutical
Aliud
Amneal Pharma
Apotex
Arrow
Laboratoires Servier
Sanofi
Mylan
Orion Pharma
Pfizer
Segment by Type
Generic
Patent

Segment by Application


Hospital
Drug Store

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Aciclovir report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Aciclovir Market Overview
1.1 Product Overview and Scope of Aciclovir
1.2 Aciclovir Segment by Type
1.2.1 Global Aciclovir Market Value Comparison by Type (2024-2034)
1.2.2 Generic
1.2.3 Patent
1.3 Aciclovir Segment by Application
1.3.1 Global Aciclovir Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Aciclovir Market Size Estimates and Forecasts
1.4.1 Global Aciclovir Revenue 2018-2034
1.4.2 Global Aciclovir Sales 2018-2034
1.4.3 Global Aciclovir Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Aciclovir Market Competition by Manufacturers
2.1 Global Aciclovir Sales Market Share by Manufacturers (2018-2024)
2.2 Global Aciclovir Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Aciclovir Average Price by Manufacturers (2018-2024)
2.4 Global Aciclovir Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Aciclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aciclovir, Product Type & Application
2.7 Aciclovir Market Competitive Situation and Trends
2.7.1 Aciclovir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aciclovir Players Market Share by Revenue
2.7.3 Global Aciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aciclovir Retrospective Market Scenario by Region
3.1 Global Aciclovir Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Aciclovir Global Aciclovir Sales by Region: 2018-2034
3.2.1 Global Aciclovir Sales by Region: 2018-2024
3.2.2 Global Aciclovir Sales by Region: 2024-2034
3.3 Global Aciclovir Global Aciclovir Revenue by Region: 2018-2034
3.3.1 Global Aciclovir Revenue by Region: 2018-2024
3.3.2 Global Aciclovir Revenue by Region: 2024-2034
3.4 North America Aciclovir Market Facts & Figures by Country
3.4.1 North America Aciclovir Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Aciclovir Sales by Country (2018-2034)
3.4.3 North America Aciclovir Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aciclovir Market Facts & Figures by Country
3.5.1 Europe Aciclovir Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Aciclovir Sales by Country (2018-2034)
3.5.3 Europe Aciclovir Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aciclovir Market Facts & Figures by Country
3.6.1 Asia Pacific Aciclovir Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Aciclovir Sales by Country (2018-2034)
3.6.3 Asia Pacific Aciclovir Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Aciclovir Market Facts & Figures by Country
3.7.1 Latin America Aciclovir Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Aciclovir Sales by Country (2018-2034)
3.7.3 Latin America Aciclovir Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aciclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Aciclovir Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Aciclovir Sales by Country (2018-2034)
3.8.3 Middle East and Africa Aciclovir Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aciclovir Sales by Type (2018-2034)
4.1.1 Global Aciclovir Sales by Type (2018-2024)
4.1.2 Global Aciclovir Sales by Type (2024-2034)
4.1.3 Global Aciclovir Sales Market Share by Type (2018-2034)
4.2 Global Aciclovir Revenue by Type (2018-2034)
4.2.1 Global Aciclovir Revenue by Type (2018-2024)
4.2.2 Global Aciclovir Revenue by Type (2024-2034)
4.2.3 Global Aciclovir Revenue Market Share by Type (2018-2034)
4.3 Global Aciclovir Price by Type (2018-2034)
5 Segment by Application
5.1 Global Aciclovir Sales by Application (2018-2034)
5.1.1 Global Aciclovir Sales by Application (2018-2024)
5.1.2 Global Aciclovir Sales by Application (2024-2034)
5.1.3 Global Aciclovir Sales Market Share by Application (2018-2034)
5.2 Global Aciclovir Revenue by Application (2018-2034)
5.2.1 Global Aciclovir Revenue by Application (2018-2024)
5.2.2 Global Aciclovir Revenue by Application (2024-2034)
5.2.3 Global Aciclovir Revenue Market Share by Application (2018-2034)
5.3 Global Aciclovir Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Greater Pharma
6.1.1 Greater Pharma Corporation Information
6.1.2 Greater Pharma Description and Business Overview
6.1.3 Greater Pharma Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Greater Pharma Aciclovir Product Portfolio
6.1.5 Greater Pharma Recent Developments/Updates
6.2 LBS Labs
6.2.1 LBS Labs Corporation Information
6.2.2 LBS Labs Description and Business Overview
6.2.3 LBS Labs Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.2.4 LBS Labs Aciclovir Product Portfolio
6.2.5 LBS Labs Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.3.4 GlaxoSmithKline Aciclovir Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Lex Ano
6.4.1 Lex Ano Corporation Information
6.4.2 Lex Ano Description and Business Overview
6.4.3 Lex Ano Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Lex Ano Aciclovir Product Portfolio
6.4.5 Lex Ano Recent Developments/Updates
6.5 Salutas
6.5.1 Salutas Corporation Information
6.5.2 Salutas Description and Business Overview
6.5.3 Salutas Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Salutas Aciclovir Product Portfolio
6.5.5 Salutas Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Novartis Aciclovir Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Teva Aciclovir Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Stada Nordic
6.8.1 Stada Nordic Corporation Information
6.8.2 Stada Nordic Description and Business Overview
6.8.3 Stada Nordic Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Stada Nordic Aciclovir Product Portfolio
6.8.5 Stada Nordic Recent Developments/Updates
6.9 Cimed Industria de Medicamentos
6.9.1 Cimed Industria de Medicamentos Corporation Information
6.9.2 Cimed Industria de Medicamentos Description and Business Overview
6.9.3 Cimed Industria de Medicamentos Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Cimed Industria de Medicamentos Aciclovir Product Portfolio
6.9.5 Cimed Industria de Medicamentos Recent Developments/Updates
6.10 Reman Drug
6.10.1 Reman Drug Corporation Information
6.10.2 Reman Drug Description and Business Overview
6.10.3 Reman Drug Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Reman Drug Aciclovir Product Portfolio
6.10.5 Reman Drug Recent Developments/Updates
6.11 L.E.T.I.
6.11.1 L.E.T.I. Corporation Information
6.11.2 L.E.T.I. Aciclovir Description and Business Overview
6.11.3 L.E.T.I. Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.11.4 L.E.T.I. Aciclovir Product Portfolio
6.11.5 L.E.T.I. Recent Developments/Updates
6.12 Nichi-Iko Pharmaceutical
6.12.1 Nichi-Iko Pharmaceutical Corporation Information
6.12.2 Nichi-Iko Pharmaceutical Aciclovir Description and Business Overview
6.12.3 Nichi-Iko Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Nichi-Iko Pharmaceutical Aciclovir Product Portfolio
6.12.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.13 Choseido Pharmaceutical
6.13.1 Choseido Pharmaceutical Corporation Information
6.13.2 Choseido Pharmaceutical Aciclovir Description and Business Overview
6.13.3 Choseido Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Choseido Pharmaceutical Aciclovir Product Portfolio
6.13.5 Choseido Pharmaceutical Recent Developments/Updates
6.14 Shiono Kemikaru
6.14.1 Shiono Kemikaru Corporation Information
6.14.2 Shiono Kemikaru Aciclovir Description and Business Overview
6.14.3 Shiono Kemikaru Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Shiono Kemikaru Aciclovir Product Portfolio
6.14.5 Shiono Kemikaru Recent Developments/Updates
6.15 Towa Yakuhin
6.15.1 Towa Yakuhin Corporation Information
6.15.2 Towa Yakuhin Aciclovir Description and Business Overview
6.15.3 Towa Yakuhin Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Towa Yakuhin Aciclovir Product Portfolio
6.15.5 Towa Yakuhin Recent Developments/Updates
6.16 Wockhardt
6.16.1 Wockhardt Corporation Information
6.16.2 Wockhardt Aciclovir Description and Business Overview
6.16.3 Wockhardt Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Wockhardt Aciclovir Product Portfolio
6.16.5 Wockhardt Recent Developments/Updates
6.17 Takata Pharmaceutical
6.17.1 Takata Pharmaceutical Corporation Information
6.17.2 Takata Pharmaceutical Aciclovir Description and Business Overview
6.17.3 Takata Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Takata Pharmaceutical Aciclovir Product Portfolio
6.17.5 Takata Pharmaceutical Recent Developments/Updates
6.18 Aliud
6.18.1 Aliud Corporation Information
6.18.2 Aliud Aciclovir Description and Business Overview
6.18.3 Aliud Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Aliud Aciclovir Product Portfolio
6.18.5 Aliud Recent Developments/Updates
6.19 Amneal Pharma
6.19.1 Amneal Pharma Corporation Information
6.19.2 Amneal Pharma Aciclovir Description and Business Overview
6.19.3 Amneal Pharma Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Amneal Pharma Aciclovir Product Portfolio
6.19.5 Amneal Pharma Recent Developments/Updates
6.20 Apotex
6.20.1 Apotex Corporation Information
6.20.2 Apotex Aciclovir Description and Business Overview
6.20.3 Apotex Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Apotex Aciclovir Product Portfolio
6.20.5 Apotex Recent Developments/Updates
6.21 Arrow
6.21.1 Arrow Corporation Information
6.21.2 Arrow Aciclovir Description and Business Overview
6.21.3 Arrow Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Arrow Aciclovir Product Portfolio
6.21.5 Arrow Recent Developments/Updates
6.22 Laboratoires Servier
6.22.1 Laboratoires Servier Corporation Information
6.22.2 Laboratoires Servier Aciclovir Description and Business Overview
6.22.3 Laboratoires Servier Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Laboratoires Servier Aciclovir Product Portfolio
6.22.5 Laboratoires Servier Recent Developments/Updates
6.23 Sanofi
6.23.1 Sanofi Corporation Information
6.23.2 Sanofi Aciclovir Description and Business Overview
6.23.3 Sanofi Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Sanofi Aciclovir Product Portfolio
6.23.5 Sanofi Recent Developments/Updates
6.24 Mylan
6.24.1 Mylan Corporation Information
6.24.2 Mylan Aciclovir Description and Business Overview
6.24.3 Mylan Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Mylan Aciclovir Product Portfolio
6.24.5 Mylan Recent Developments/Updates
6.25 Orion Pharma
6.25.1 Orion Pharma Corporation Information
6.25.2 Orion Pharma Aciclovir Description and Business Overview
6.25.3 Orion Pharma Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.25.4 Orion Pharma Aciclovir Product Portfolio
6.25.5 Orion Pharma Recent Developments/Updates
6.26 Pfizer
6.26.1 Pfizer Corporation Information
6.26.2 Pfizer Aciclovir Description and Business Overview
6.26.3 Pfizer Aciclovir Sales, Revenue and Gross Margin (2018-2024)
6.26.4 Pfizer Aciclovir Product Portfolio
6.26.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aciclovir Industry Chain Analysis
7.2 Aciclovir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aciclovir Production Mode & Process
7.4 Aciclovir Sales and Marketing
7.4.1 Aciclovir Sales Channels
7.4.2 Aciclovir Distributors
7.5 Aciclovir Customers
8 Aciclovir Market Dynamics
8.1 Aciclovir Industry Trends
8.2 Aciclovir Market Drivers
8.3 Aciclovir Market Challenges
8.4 Aciclovir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Aciclovir Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Aciclovir Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Aciclovir Market Competitive Situation by Manufacturers in 2022
Table 4. Global Aciclovir Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Aciclovir Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Aciclovir Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Aciclovir Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Aciclovir Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Aciclovir, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Aciclovir, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aciclovir, Product Type & Application
Table 12. Global Key Manufacturers of Aciclovir, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aciclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aciclovir as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aciclovir Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Aciclovir Sales by Region (2018-2024) & (K Units)
Table 18. Global Aciclovir Sales Market Share by Region (2018-2024)
Table 19. Global Aciclovir Sales by Region (2024-2034) & (K Units)
Table 20. Global Aciclovir Sales Market Share by Region (2024-2034)
Table 21. Global Aciclovir Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Aciclovir Revenue Market Share by Region (2018-2024)
Table 23. Global Aciclovir Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Aciclovir Revenue Market Share by Region (2024-2034)
Table 25. North America Aciclovir Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Aciclovir Sales by Country (2018-2024) & (K Units)
Table 27. North America Aciclovir Sales by Country (2024-2034) & (K Units)
Table 28. North America Aciclovir Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Aciclovir Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Aciclovir Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Aciclovir Sales by Country (2018-2024) & (K Units)
Table 32. Europe Aciclovir Sales by Country (2024-2034) & (K Units)
Table 33. Europe Aciclovir Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Aciclovir Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Aciclovir Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Aciclovir Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Aciclovir Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Aciclovir Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Aciclovir Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Aciclovir Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Aciclovir Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Aciclovir Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Aciclovir Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Aciclovir Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Aciclovir Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Aciclovir Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Aciclovir Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Aciclovir Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Aciclovir Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Aciclovir Sales (K Units) by Type (2018-2024)
Table 51. Global Aciclovir Sales (K Units) by Type (2024-2034)
Table 52. Global Aciclovir Sales Market Share by Type (2018-2024)
Table 53. Global Aciclovir Sales Market Share by Type (2024-2034)
Table 54. Global Aciclovir Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Aciclovir Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Aciclovir Revenue Market Share by Type (2018-2024)
Table 57. Global Aciclovir Revenue Market Share by Type (2024-2034)
Table 58. Global Aciclovir Price (US$/Unit) by Type (2018-2024)
Table 59. Global Aciclovir Price (US$/Unit) by Type (2024-2034)
Table 60. Global Aciclovir Sales (K Units) by Application (2018-2024)
Table 61. Global Aciclovir Sales (K Units) by Application (2024-2034)
Table 62. Global Aciclovir Sales Market Share by Application (2018-2024)
Table 63. Global Aciclovir Sales Market Share by Application (2024-2034)
Table 64. Global Aciclovir Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Aciclovir Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Aciclovir Revenue Market Share by Application (2018-2024)
Table 67. Global Aciclovir Revenue Market Share by Application (2024-2034)
Table 68. Global Aciclovir Price (US$/Unit) by Application (2018-2024)
Table 69. Global Aciclovir Price (US$/Unit) by Application (2024-2034)
Table 70. Greater Pharma Corporation Information
Table 71. Greater Pharma Description and Business Overview
Table 72. Greater Pharma Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Greater Pharma Aciclovir Product
Table 74. Greater Pharma Recent Developments/Updates
Table 75. LBS Labs Corporation Information
Table 76. LBS Labs Description and Business Overview
Table 77. LBS Labs Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. LBS Labs Aciclovir Product
Table 79. LBS Labs Recent Developments/Updates
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. GlaxoSmithKline Aciclovir Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Lex Ano Corporation Information
Table 86. Lex Ano Description and Business Overview
Table 87. Lex Ano Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Lex Ano Aciclovir Product
Table 89. Lex Ano Recent Developments/Updates
Table 90. Salutas Corporation Information
Table 91. Salutas Description and Business Overview
Table 92. Salutas Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Salutas Aciclovir Product
Table 94. Salutas Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Novartis Aciclovir Product
Table 99. Novartis Recent Developments/Updates
Table 100. Teva Corporation Information
Table 101. Teva Description and Business Overview
Table 102. Teva Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Teva Aciclovir Product
Table 104. Teva Recent Developments/Updates
Table 105. Stada Nordic Corporation Information
Table 106. Stada Nordic Description and Business Overview
Table 107. Stada Nordic Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Stada Nordic Aciclovir Product
Table 109. Stada Nordic Recent Developments/Updates
Table 110. Cimed Industria de Medicamentos Corporation Information
Table 111. Cimed Industria de Medicamentos Description and Business Overview
Table 112. Cimed Industria de Medicamentos Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Cimed Industria de Medicamentos Aciclovir Product
Table 114. Cimed Industria de Medicamentos Recent Developments/Updates
Table 115. Reman Drug Corporation Information
Table 116. Reman Drug Description and Business Overview
Table 117. Reman Drug Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Reman Drug Aciclovir Product
Table 119. Reman Drug Recent Developments/Updates
Table 120. L.E.T.I. Corporation Information
Table 121. L.E.T.I. Description and Business Overview
Table 122. L.E.T.I. Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. L.E.T.I. Aciclovir Product
Table 124. L.E.T.I. Recent Developments/Updates
Table 125. Nichi-Iko Pharmaceutical Corporation Information
Table 126. Nichi-Iko Pharmaceutical Description and Business Overview
Table 127. Nichi-Iko Pharmaceutical Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Nichi-Iko Pharmaceutical Aciclovir Product
Table 129. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 130. Choseido Pharmaceutical Corporation Information
Table 131. Choseido Pharmaceutical Description and Business Overview
Table 132. Choseido Pharmaceutical Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Choseido Pharmaceutical Aciclovir Product
Table 134. Choseido Pharmaceutical Recent Developments/Updates
Table 135. Shiono Kemikaru Corporation Information
Table 136. Shiono Kemikaru Description and Business Overview
Table 137. Shiono Kemikaru Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Shiono Kemikaru Aciclovir Product
Table 139. Shiono Kemikaru Recent Developments/Updates
Table 140. Towa Yakuhin Corporation Information
Table 141. Towa Yakuhin Description and Business Overview
Table 142. Towa Yakuhin Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Towa Yakuhin Aciclovir Product
Table 144. Towa Yakuhin Recent Developments/Updates
Table 145. Wockhardt Corporation Information
Table 146. Wockhardt Description and Business Overview
Table 147. Wockhardt Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Wockhardt Aciclovir Product
Table 149. Wockhardt Recent Developments/Updates
Table 150. Takata Pharmaceutical Corporation Information
Table 151. Takata Pharmaceutical Description and Business Overview
Table 152. Takata Pharmaceutical Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Takata Pharmaceutical Aciclovir Product
Table 154. Takata Pharmaceutical Recent Developments/Updates
Table 155. Aliud Corporation Information
Table 156. Aliud Description and Business Overview
Table 157. Aliud Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Aliud Aciclovir Product
Table 159. Aliud Recent Developments/Updates
Table 160. Amneal Pharma Corporation Information
Table 161. Amneal Pharma Description and Business Overview
Table 162. Amneal Pharma Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Amneal Pharma Aciclovir Product
Table 164. Amneal Pharma Recent Developments/Updates
Table 165. Apotex Corporation Information
Table 166. Apotex Description and Business Overview
Table 167. Apotex Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Apotex Aciclovir Product
Table 169. Apotex Recent Developments/Updates
Table 170. Arrow Corporation Information
Table 171. Arrow Description and Business Overview
Table 172. Arrow Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Arrow Aciclovir Product
Table 174. Arrow Recent Developments/Updates
Table 175. Laboratoires Servier Corporation Information
Table 176. Laboratoires Servier Description and Business Overview
Table 177. Laboratoires Servier Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Laboratoires Servier Aciclovir Product
Table 179. Laboratoires Servier Recent Developments/Updates
Table 180. Sanofi Corporation Information
Table 181. Sanofi Description and Business Overview
Table 182. Sanofi Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Sanofi Aciclovir Product
Table 184. Sanofi Recent Developments/Updates
Table 185. Mylan Corporation Information
Table 186. Mylan Description and Business Overview
Table 187. Mylan Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Mylan Aciclovir Product
Table 189. Mylan Recent Developments/Updates
Table 190. Orion Pharma Corporation Information
Table 191. Orion Pharma Description and Business Overview
Table 192. Orion Pharma Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 193. Orion Pharma Aciclovir Product
Table 194. Orion Pharma Recent Developments/Updates
Table 195. Pfizer Corporation Information
Table 196. Pfizer Description and Business Overview
Table 197. Pfizer Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 198. Pfizer Aciclovir Product
Table 199. Pfizer Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Aciclovir Distributors List
Table 203. Aciclovir Customers List
Table 204. Aciclovir Market Trends
Table 205. Aciclovir Market Drivers
Table 206. Aciclovir Market Challenges
Table 207. Aciclovir Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Aciclovir
Figure 2. Global Aciclovir Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Aciclovir Market Share by Type in 2022 & 2034
Figure 4. Generic Product Picture
Figure 5. Patent Product Picture
Figure 6. Global Aciclovir Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Aciclovir Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Global Aciclovir Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 11. Global Aciclovir Market Size (2018-2034) & (US$ Million)
Figure 12. Global Aciclovir Sales (2018-2034) & (K Units)
Figure 13. Global Aciclovir Average Price (US$/Unit) & (2018-2034)
Figure 14. Aciclovir Report Years Considered
Figure 15. Aciclovir Sales Share by Manufacturers in 2022
Figure 16. Global Aciclovir Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Aciclovir Players: Market Share by Revenue in 2022
Figure 18. Aciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Aciclovir Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 20. North America Aciclovir Sales Market Share by Country (2018-2034)
Figure 21. North America Aciclovir Revenue Market Share by Country (2018-2034)
Figure 22. United States Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Aciclovir Sales Market Share by Country (2018-2034)
Figure 25. Europe Aciclovir Revenue Market Share by Country (2018-2034)
Figure 26. Germany Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Aciclovir Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Aciclovir Revenue Market Share by Region (2018-2034)
Figure 33. China Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. China Taiwan Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Latin America Aciclovir Sales Market Share by Country (2018-2034)
Figure 43. Latin America Aciclovir Revenue Market Share by Country (2018-2034)
Figure 44. Mexico Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Brazil Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Argentina Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Aciclovir Sales Market Share by Country (2018-2034)
Figure 48. Middle East & Africa Aciclovir Revenue Market Share by Country (2018-2034)
Figure 49. Turkey Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. UAE Aciclovir Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Aciclovir by Type (2018-2034)
Figure 53. Global Revenue Market Share of Aciclovir by Type (2018-2034)
Figure 54. Global Aciclovir Price (US$/Unit) by Type (2018-2034)
Figure 55. Global Sales Market Share of Aciclovir by Application (2018-2034)
Figure 56. Global Revenue Market Share of Aciclovir by Application (2018-2034)
Figure 57. Global Aciclovir Price (US$/Unit) by Application (2018-2034)
Figure 58. Aciclovir Value Chain
Figure 59. Aciclovir Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed